Fish oil attenuated dystrophic muscle markers of inflammation via FFA1 and FFA4 in the mdx mouse model of DMD
- 2 November 2020
- journal article
- research article
- Published by Wiley in The Anatomical Record
- Vol. 304 (6) , 1305-1312
Abstract
In the present study we investigated the involvement of free fatty acid (FFA) receptors in the anti‐inflammatory role of eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) in dystrophic muscles, by administering FFA blockers in the mdx mouse model of dystrophy. Mdx mice (3 months‐old) were treated with fish oil capsules (FDC Vitamins; 0.4 g EPA and 0.2 g DHA; gavage) alone or concomitant to FFA1 and FFA4 blockers (GW1100 and AH7614; i.p.). C57BL/10 mice (3 months‐old) and untreated‐mdx mice received mineral oil and were used as controls. After 1 month of treatment, plasma markers of myonecrosis (total and cardiac creatine kinase; CK), the levels of FFA1 and FFA4 and of the markers of inflammation, nuclear transcription factor kappa B (NFkB), tumor necrosis factor alpha (TNF‐α) and interleukin 1β (IL‐1β) were analyzed in the diaphragm muscle and heart by western blot. Fish oil significantly reduced total CK, cardiac CK and the levels of NFkB (diaphragm), and of TNF‐α and IL‐1β (diaphragm and heart) in mdx. In the dystrophic diaphragm, FFA1 was increased compared to normal. Blockers of FFA1 and FFA4 significantly inhibited the effects of fish oil treatment in both dystrophic muscles. The anti‐inflammatory effects of fish oil in dystrophic diaphragm muscle and heart were mediated through FFA1 and FFA4.Keywords
Funding Information
- Conselho Nacional de Desenvolvimento Científico e Tecnológico (302012‐2017‐6)
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (001)
- Fundação de Amparo à Pesquisa do Estado de São Paulo (2017/24051‐4)
This publication has 35 references indexed in Scilit:
- Omega‐3 polyunsaturated fatty acids and inflammatory processes: nutrition or pharmacology?British Journal of Clinical Pharmacology, 2012
- Suramin affects metalloproteinase‐9 activity and increases beta‐dystroglycan levels in the diaphragm of the dystrophin‐deficient mdx MOUSEMuscle & Nerve, 2012
- The role of G-protein-coupled receptors in mediating the effect of fatty acids on inflammation and insulin sensitivityCurrent Opinion in Clinical Nutrition and Metabolic Care, 2011
- Blockade of TNF in vivo using cV1q antibody reduces contractile dysfunction of skeletal muscle in response to eccentric exercise in dystrophic mdx and normal miceNeuromuscular Disorders, 2011
- Diet-induced Obesity Up-regulates the Abundance of GPR43 and GPR120 in a Tissue Specific MannerCellular Physiology and Biochemistry, 2011
- GPR120 Is an Omega-3 Fatty Acid Receptor Mediating Potent Anti-inflammatory and Insulin-Sensitizing EffectsCell, 2010
- Pharmacological regulation of insulin secretion in MIN6 cells through the fatty acid receptor GPR40: identification of agonist and antagonist small moleculesBritish Journal of Pharmacology, 2006
- MUSCLE DAMAGE IN MDX (DYSTROPHIC) MICE: ROLE OF CALCIUM AND REACTIVE OXYGEN SPECIESClinical and Experimental Pharmacology and Physiology, 2006
- Free fatty acids regulate insulin secretion from pancreatic β cells through GPR40Nature, 2003
- The mdx mouse diaphragm reproduces the degenerative changes of Duchenne muscular dystrophyNature, 1991